logo
Select company
Select metric
-7.46Interest Coverage
VS
Market
21
Sector
50
Industry
70
History
50
$ 1.32Close
$ 1.09 - $ 16.95 52-Week Range
Ticker Information

Ticker

ERNA

Company Name

ERNEXA THERAPEUTICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

ERNEXA THERAPEUTICS INC - Interest Coverage Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

ERNA - Int. Coverage Historical data
DateEarning Before Interest & Taxes (EBIT)Interest ExpenseInterest Coverage
6/30/2025$ -38.51M$ 5.16M-7.46
3/31/2025$ -40.1M$ 5.96M-6.73
12/31/2024$ -37.76M$ 6.75M-5.59
9/30/2024$ -41.03M$ 3.88M-10.57
6/30/2024$ -21.73M$ 2.2M-9.89
3/31/2024$ -21.5M$ 1.4M-15.36
12/31/2023$ -21.06M$ 614K-34.29
9/30/2023$ -19.96M$ 00
6/30/2023$ -21.68M$ 00
3/31/2023$ -20.57M$ 00
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • ERNEXA THERAPEUTICS INC's latest trailing twelve months (TTM) Int. Coverage stands at -23.26.
  • Over the past 5 years, ERNEXA THERAPEUTICS INC's average Int. Coverage has been -110.42.
  • The median Int. Coverage for ERNEXA THERAPEUTICS INC during this period was -19.31
  • ERNEXA THERAPEUTICS INC reached its highest Int. Coverage over the past 5 years at -5.59.
  • The lowest Int. Coverage recorded by ERNEXA THERAPEUTICS INC in the same timeframe -821.6

ERNEXA THERAPEUTICS INC's Int. Coverage vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

Int. Coverage Benchmarks
CompanyInt. Coverage
BRTX : BIORESTORATIVE THERAPIES INC -VYNE : VYNE THERAPEUTICS INC -IBIO : IBIO INC -85.68LEXX : LEXARIA BIOSCIENCE CORP -LYRA : LYRA THERAPEUTICS INC -PULM : PULMATRIX INC -APRE : APREA THERAPEUTICS INC -HCWB : HCW BIOLOGICS INC -10.92MGRX : MANGOCEUTICALS INC -PHIO : PHIO PHARMACEUTICALS CORP -

Definition of Interest Coverage

[Calculation] The Interest Coverage Ratio is a debt and profitability ratio that describes how easily a business can pay interest on its outstanding [Debt]. It is calculated by dividing the company’s earnings before interest and taxes [EBIT] by its interest expenses [IntExp].
EBIT / Int. Exp.
(=) Int. Coverage
Int. Coverage for ERNEXA THERAPEUTICS INC is calculated as follows: EBIT [ $ -5.79M ] / Int. Exp. [ $ 249K ]
(=) Int. Coverage [ -23.26 ]

ERNA - Interest Coverage, Last 5 years

-821.6

Minimum

Sep 30, 2021

-5.59

Maximum

Dec 31, 2024

-110.42

Average

-19.31

Median

Int. Coverage Benchmark Analysis

The chart above depicts the distribution of Int. Coverage for companies in the Total Stock Market. The average Int. Coverage of the companies is 2.15 with a standard deviation of 8.43.
The following table provides additional summary stats:
Int. Coverage in the Market:
filtered constituents2.37K
min-25.49
max28.75
average2.15
median2.08
std8.43